From: MicroRNA-21 expression is associated with overall survival in patients with glioma
Clinicopathological features | No. of cases | miR-21 expression | P | |
---|---|---|---|---|
Low (n, %) | High (n,%) | |||
WHO Grade | <0.001 | |||
I | 31 | 31 (100%) | 0 (0%) | |
II | 30 | 30 (100%) | 0 (0%) | |
III | 32 | 18 (56.3%) | 14 (43.7%) | |
IV | 59 | 3 (5%) | 56 (95%) | |
Gender | 0.34 | |||
Male | 78 | 45 (57.7%) | 33 (42.3%) | |
Female | 74 | 37 (50%) | 37 (50%) | |
Age | 0.23 | |||
<50 | 91 | 49 (53.8%) | 42 (46.2%) | |
≥50 | 61 | 33 (54.1%) | 28 (45.9%) | |
KPS | <0.001 | |||
≥70 | 62 | 57 (91.9%) | 5 (8.1%) | |
<70 | 90 | 25 (27.8%) | 65 (72.2%) |